-
1
-
-
79952123613
-
A mechanistic rationale forMEKinhibitor therapy in myeloma based on blockade ofMAFoncogene expression
-
Annunziata CM, Hernandez L, Davis RE, et al. A mechanistic rationale forMEKinhibitor therapy in myeloma based on blockade ofMAFoncogene expression. Blood. 2011;117(8):2396-2404.
-
(2011)
Blood
, vol.117
, Issue.8
, pp. 2396-2404
-
-
Annunziata, C.M.1
Hernandez, L.2
Davis, R.E.3
-
2
-
-
33745779502
-
The molecular classification of multiple myeloma
-
Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood. 2006;108(6):2020-2028.
-
(2006)
Blood
, vol.108
, Issue.6
, pp. 2020-2028
-
-
Zhan, F.1
Huang, Y.2
Colla, S.3
-
3
-
-
1442285889
-
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
-
DOI 10.1016/S1535-6108(04)00019-4, PII S1535610804000194
-
Hurt EM, Wiestner A, Rosenwald A, et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell. 2004;5(2): 191-199. (Pubitemid 38283804)
-
(2004)
Cancer Cell
, vol.5
, Issue.2
, pp. 191-199
-
-
Hurt, E.M.1
Wiestner, A.2
Rosenwald, A.3
Shaffer, A.L.4
Campo, E.5
Grogan, T.6
Bergsagel, P.L.7
Kuehl, W.M.8
Staudt, L.M.9
-
4
-
-
78650978001
-
The MMSEThistone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
-
Martinez-Garcia E, Popovic R, Min DJ, et al. The MMSEThistone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117(1):211-220.
-
(2011)
Blood
, vol.117
, Issue.1
, pp. 211-220
-
-
Martinez-Garcia, E.1
Popovic, R.2
Min, D.J.3
-
5
-
-
58149232433
-
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells
-
Brito JL, Walker B, Jenner M, et al.MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica. 2009;94(1): 78-86.
-
(2009)
Haematologica
, vol.94
, Issue.1
, pp. 78-86
-
-
Brito, J.L.1
Walker, B.2
Jenner, M.3
-
6
-
-
38349087546
-
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity
-
Lauring J, Abukhdeir AM, Konishi H, et al. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood. 2008;111(2):856-864.
-
(2008)
Blood
, vol.111
, Issue.2
, pp. 856-864
-
-
Lauring, J.1
Abukhdeir, A.M.2
Konishi, H.3
-
7
-
-
31144453233
-
BRAF mutation predicts sensitivity to MEK inhibition
-
DOI 10.1038/nature04304, PII NATURE04304
-
Solit DB, Garraway LA, Pratilas CA, et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature. 2006; 439(7074):358-362. (Pubitemid 43128863)
-
(2006)
Nature
, vol.439
, Issue.7074
, pp. 358-362
-
-
Solit, D.B.1
Garraway, L.A.2
Pratilas, C.A.3
Sawai, A.4
Getz, G.5
Basso, A.6
Ye, Q.7
Lobo, J.M.8
She, Y.9
Osman, I.10
Golub, T.R.11
Sebolt-Leopold, J.12
Sellers, W.R.13
Rosen, N.14
-
8
-
-
34548844157
-
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis
-
DOI 10.1182/blood-2007-03-081240
-
Tai YT, Fulciniti M, Hideshima T, et al. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. Blood. 2007;110(5):1656-1663. (Pubitemid 47443984)
-
(2007)
Blood
, vol.110
, Issue.5
, pp. 1656-1663
-
-
Tai, Y.-T.1
Fulciniti, M.2
Hideshima, T.3
Song, W.4
Leiba, M.5
Li, X.-F.6
Rumizen, M.7
Burger, P.8
Morrison, A.9
Podar, K.10
Chauhan, D.11
Tassone, P.12
Richardson, P.13
Munshi, N.C.14
Ghobrial, I.M.15
Anderson, K.C.16
-
9
-
-
77957738022
-
Impressions of the myeloma landscape
-
Bergsagel PL. Impressions of the myeloma landscape. Blood. 2010;116(14):2403-2404.
-
(2010)
Blood
, vol.116
, Issue.14
, pp. 2403-2404
-
-
Bergsagel, P.L.1
|